Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842306 · ClinicalTrials.gov registry record
End-tidal Oxygen Can Reliably Predict the Arterial Partial Pressure of Oxygen Among Emergency Department Patients
A clinical trial, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- 75
- Enrollment target
NCT03842306 is a clinical trial that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 75 participants.
The verdict
NCT03842306 has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Recent studies have shown that end tidal oxygen (ETO2) monitoring can be useful to determine the adequacy of preoxygenation. No study has assessed the correlation between ETO2 values obtained during preoxygenation to predict the PaO2 in patients undergoing RSI in the ED. Our objective was to determine whether a novel equation using the ETO2 at the end of preoxygenation could reliably estimate the partial pressure of arterial oxygen (PaO2) in critically-ill ED patients undergoing RSI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-10-15 |
| Est. Completion | 2017-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03842306
The ClinicalTrials.gov registry entry for NCT03842306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York City Health and Hospitals Corporation, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03842306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03842306 about?
NCT03842306 is a clinical study titled "End-tidal Oxygen Can Reliably Predict the Arterial Partial Pressure of Oxygen Among Emergency Department Patients". Recent studies have shown that end tidal oxygen (ETO2) monitoring can be useful to determine the adequacy of preoxygenation. No study has assessed the correlation between ETO2 values obtained during preoxygenation to predict the PaO2 in patients undergoing RSI in the ED. Our objective was to determi...
What is the current status of trial NCT03842306?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2017-10-15. Estimated completion is 2017-12-30.
Who is sponsoring clinical trial NCT03842306?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.